| abstract |
Monoclonal neutralizing antibodies that specifically bind HIV-1 gp120 and antigen-binding fragments of these antibodies are disclosed. Nucleic acids, vectors, and host cells encoding these antibodies are also provided. Methods of using these antibodies to detect HIV are disclosed. Further, the use of these antibodies, antigen binding fragments, nucleic acids and vectors for the prevention and/or treatment of HIV infection is disclosed. |